In The News Posted December 19, 2020 Share Posted December 19, 2020 NEW YORK, Dec. 18, 2020 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of BioTelemetry, Inc. ("BioTelemetry" or the "Company") (NASDAQ: BEAT) in connection with the proposed acquisition of the Company...View the full article Quote Link to comment Share on other sites More sharing options...
Recommended Posts